The effectiveness of aducanumab and donanemab in treating Alzheimer's disease (AD) was successfully simulated using a novel computer model, demonstrating...
Read moreIn recent years, the high cost of gene therapies has emerged as a major barrier to the development of personalised...
Read moreAccording to new research by Katie Porter, U.S. Democratic Representative and a consumer bankruptcy law professor vying for re-election in...
Read moreAs anticipated, Congress swiftly reauthorized four important user fee programmes as part of a bill that was essential to passing...
Read moreBy comparing tumour samples taken before and after treatment, a new clinical trial platform called Brain-POP (brain perioperative) will allow...
Read moreAccording to a recent data study by the Institute for Public Policy Research, the UK's share of worldwide research and...
Read moreGene therapy remains a topic of fascination to biopharmaceutical dealmakers despite safety worries and opposition from drug regulators, as seen...
Read moreOne of the most difficult medical research findings, drug distribution still faces a lot of challenges, including surviving the acidic...
Read moreDeals can be just as significant in the drug development industry as scientific advancements. Without mergers and acquisitions, many of...
Read moreAccording to new research, ancient infections that left viral DNA in human genomes act as antivirals to shield human cells...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.